# US 2006/0069230 A1 · Biodegradable polyketal polymers and methods for their formation and use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0069230 A1
- Document ID: US20060069230A1
- Status: Published application
- Kind: A1
- Application number: 10/501,565
- Filed: 2003-01-14
- Published: 2006-03-30
- Earliest claimed: 2002-01-14
- Assignees: The General Hospital Corporation
- Inventors: Mikhail Papisov
- Web page: https://patentgrep.com/patent/US20060069230A1

## CPC

- C08G 16/04: Chemically modified polycondensates
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- C08G 4/00: Condensation polymers of aldehydes or ketones with polyalcohols; Addition polymers of heterocyclic oxygen compounds containing in the ring at least once the grouping —O—C—O— (of cyclic oligomers of aldehydes C08G2/00)
- C08L 59/02: Polyacetals containing polyoxymethylene sequences only
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention relates to biodegradable biocompatible polyketals, methods for their preparation, and methods for treating animals by administration of biodegradable biocompatible polyketals. In one aspect, a method for forming the biodegradable biocompatible polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a reducing agent to form the biodegradable biocompatible polyketal. The resultant biodegradable biocompatible polyketals can be chemically modified to incorporate additional hydrophilic moieties. A method for treating animals includes the administration of the biodegradable biocompatible polyketal in which biologically active compounds or diagnostic labels can be disposed. The present invention also relates to chiral polyketals, methods for their preparation, and methods for use in chromatographic applications, specifically in chiral separations. A method for forming the chiral polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a suitable reagent to form the chiral polyketal. A method for use in chiral separations includes the incorporation of the chiral polyketals in the mobile phase during a chromatographic separation, or into chiral stationary phases such as gels. The present invention further relates to chiral polyketals as a source for chiral compounds, and methods for generating such chiral compounds.

## Claims

### Claim 1

A biodegradable biocompatible polyketal comprising repeat structural units, wherein substantially all the structural units comprise:
a) at least one ketal group wherein at least one ketal oxygen atom is within the polymer main chain; and
b) at least one hydrophilic group or pharmaceutically useful group.

### Claim 2 (depends on 1)

The biodegradable biocompatible polyketal of claim 1 wherein at least a subset of the structural units have the structure:
wherein each occurrence of R1 and R2 is independently a biocompatible group and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is a biocompatible group and is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3, R4, R5 and R6 is a hydrophilic group or a pharmaceutically useful group.

### Claim 3 (depends on 1)

The biodegradable biocompatible polyketal of claim 1 wherein at least a subset of the structural units have the structure:
wherein each occurrence of R1 is a biocompatible group;
each occurrence of R2 is a biocompatible group and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C1;
n is an integer;
each occurrence of R1, R3 and R4 is a biocompatible group and is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3, and R4 is a hydrophilic group or a pharmaceutically useful group.

### Claim 4 (depends on 1)

The biodegradable biocompatible polyketal of claim 1 wherein at least a subset of the structural units have the structure:
wherein n is an integer.

### Claim 5 (depends on 1)

The biodegradable biocompatible polyketal of claim 1 wherein at least a subset of the structural units have the structure:
wherein n is an integer.

### Claim 6 (depends on 4)

The biodegradable biocompatible polyketal of claim 4 wherein at least a subset of the structural units have the structure:
wherein n is an integer.

### Claim 7 (depends on 5)

The biodegradable biocompatible polyketal of claim 5 wherein at least a subset of the structural units have the structure:
wherein n is an integer.

### Claim 8 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein the organic moiety is selected from the group consisting of: aliphatic groups having a chain of atoms in a range of between about one and twelve atoms, hydroxyl, hydroxyalkyl, amine, carboxyl, amide, carboxylic ester, thioester, aldehyde, nitryl, isonitryl, nitroso, hydroxylamine, mercaptoalkyl, heterocycle, carbamates, carboxylic acids and their salts, sulfonic acids and their salts, sulfonic acid esters, phosphoric acids and their salts, phosphate esters, polyglycol ethers, polyamines, polycarboxylates, polyesters, polythioesters, pharmaceutically useful groups, a biologically active substance or a diagnostic label.

### Claim 9 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein the organic moiety is a hydroxyalkyl group.

### Claim 10 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein at least one of R1, R2, R3, R4, R5 and R6 comprises a carboxyl group.

### Claim 11 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein at least one of R1, R2, R3, R4, R5 and R6 comprises an aldehyde group.

### Claim 12 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein at least one of R1, R2, R3, R4, R5 and R6 comprises a methylol group or a glycol group.

### Claim 13 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein R1, R2, R3, R4, R5 and R6 comprise a methylol group or a glycol group.

### Claim 14 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein R1 and R2 are methylol or glycol and R3, R4, R5 and R6 are hydrogen.

### Claim 15 (depends on 1, 2, 3)

A crosslinked biodegradable biocompatible polyketal, comprising a compound of any one of claims 1, 2 or 3.

### Claim 16 (depends on 15)

The biodegradable biocompatible polyketal of claim 15 wherein said polyketal is crosslinked with a crosslinking agent having the structure:
X1—(R)—X2;
wherein R is a spacer group and wherein X1 and X2 are reactive groups.

### Claim 17 (depends on 16)

The biodegradable biocompatible polyketal of claim 16 wherein said reactive groups X1 and X2 are independently selected from the group consisting of: epoxides, halides, tosylates, carboxylates, aziridines, cyclopropanes, esters, N-oxysuccinimide esters, disulfides, anhydrides, amines, polyols, thiols, alcohols, ketones, aldehydes, diazocompounds, boron derivatives, ylides, isonitriles, hydrazines and their derivatives, and hydroxylamines and their derivatives.

### Claim 18 (depends on 16)

The biodegradable biocompatible polyketal of claim 16 wherein said crosslinking agent is present in an amount in a range of about one and twenty-five percent by weight of said polyketal.

### Claim 19 (depends on 18)

The biodegradable biocompatible polyketal of claim 18 wherein said crosslinking agent is epibromohydrin.

### Claim 20 (depends on 18)

The biodegradable biocompatible polyketal of claim 18 wherein said crosslinking agent is epichlorohydrin.

### Claim 21 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said polyketal has a molecular weight between about 0.5 kDa and 1500 kDa.

### Claim 22 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said polyketal has a molecular weight between about 1.0 and 1000 kDa.

### Claim 23 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said polyketal is a stereoregular isotactic compound.

### Claim 24 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said polyketal is racemic.

### Claim 25 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said polyketal is chiral or optically active.

### Claim 26 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein at least one of R1, R2, R3, R4, R5 and R6 is a nitrogen-containing moiety.

### Claim 27 (depends on 26)

The biodegradable biocompatible polyketal of claim 26 wherein said nitrogen-containing moiety is a crosslinking agent.

### Claim 28 (depends on 26)

The biodegradable biocompatible polyketal of claim 26 wherein said nitrogen-containing moiety has the structure —CmH2mNR7R8, wherein m is an integer, and wherein R7 and R8 are independently hydrogen, organic or inorganic substitutents.

### Claim 29 (depends on 26)

The biodegradable biocompatible polyketal of claim 26 wherein said nitrogen-containing moiety is a pharmaceutically useful group, a drug, a macromolecule or a diagnostic label.

### Claim 30 (depends on 2, 3)

The biodegradable biocompatible polyketal of claim 2 or 3 wherein said biodegradable biocompatible polyketal is associated with a pharmaceutically useful group, a drug, a macromolecule or a diagnostic label.

### Claim 31 (depends on 29)

The biodegradable biocompatible polyketal of claim 29 wherein said pharmaceutically useful group is selected from the group consisting of: a hydrophilicity/hydrophobicity modifier, a pharmacokinetic modifier, an antigen, a receptor ligand, a nucleotide, a chemotherapeutic agent, an antibacterial agent, an antiviral agent, an immunomodulator, a hormone or analog thereof, an enzyme, an inhibitor, an alkaloid and a therapeutic radionuclide.

### Claim 32 (depends on 30)

The biodegradable biocompatible polyketal of claim 30 wherein said pharmaceutically useful group is selected from the group consisting of: a hydrophilicity/hydrophobicity modifier, a pharmacokinetic modifier, an antigen, a receptor ligand, a nucleotide, a chemotherapeutic agent, an antibacterial agent, an antiviral agent, an immunomodulator, a hormone or analog thereof, an enzyme, an inhibitor, an alkaloid and a therapeutic radionuclide.

### Claim 33 (depends on 29)

The biodegradable biocompatible polyketal of claim 29 wherein said drug is selected from the group consisting of: vitamins, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anti-convulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti-glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and anti-adhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, anti-hypertensives, analgesics, anti-pyretics, steroidal and non-steroidal anti-inflammatory agents, anti-angiogenic factors, anti-secretory factors, anticoagulants and/or antithrombotic agents, local anesthetics, ophthalmics, prostaglandins, anti-depressants, anti-psychotic substances, anti-emetics, and imaging agents.

### Claim 34 (depends on 30)

The biodegradable biocompatible polyketal of claim 30 wherein said drug is selected from the group consisting of: vitamins, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anti-convulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti-glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and anti-adhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, anti-hypertensives, analgesics, anti-pyretics, steroidal and non-steroidal anti-inflammatory agents, anti-angiogenic factors, anti-secretory factors, anticoagulants and/or antithrombotic agents, local anesthetics, ophthalmics, prostaglandins, anti-depressants, anti-psychotic substances, anti-emetics, and imaging agents.

### Claim 35 (depends on 33)

The biodegradable biocompatible polyketal of claim 33 wherein the chemotherapeutic agent is selected from the group consisting of: topoisomerase I and II inhibitors, alkylating agents, anthracyclines, doxorubicin, cisplastin, carboplatin, vincristine, mitromycine, taxol, camptothecin, antisense oligonucleotides, ribozymes, and dactinomycines.

### Claim 36 (depends on 34)

The biodegradable biocompatible polyketal of claim 34 wherein the chemotherapeutic agent is selected from the group consisting of: topoisomerase I and II inhibitors, alkylating agents, anthracyclines, doxorubicin, cisplastin, carboplatin, vincristine, mitromycine, taxol, camptothecin, antisense oligonucleotides, ribozymes, and dactinomycines.

### Claim 37 (depends on 29)

The biodegradable biocompatible polyketal of claim 29 wherein said macromolecule is selected from the group consisting of: enzyme, polypeptide, protein, lipid, polyelectrolyte, antibody, and lectin; and is optionally chemically modified prior to being associated with said biodegradable biocompatible polyketal.

### Claim 38 (depends on 30)

The biodegradable biocompatible polyketal of claim 30 wherein said macromolecule is selected from the group consisting of: enzyme, polypeptide, protein, lipid, polyelectrolyte, antibody, and lectin; and is optionally chemically modified prior to being associated with said biodegradable biocompatible polyketal.

### Claim 39 (depends on 37)

The biodegradable biocompatible polyketal of claim 37 wherein said polypeptide is polylysine.

### Claim 40 (depends on 38)

The biodegradable biocompatible polyketal of claim 38 wherein said polypeptide is polylysine.

### Claim 41 (depends on 29)

The biodegradable biocompatible polyketal of claim 29 wherein said diagnostic label is selected from the group consisting of: radiopharmaceutical or radioactive isotopes for gamma scintigraphy and PET, contrast agent for Magnetic Resonance Imaging (MRI), contrast agent for computed tomography, contrast agent for X-ray imaging method, agent for ultrasound diagnostic method, agent for neutron activation, moiety which can reflect, scatter or affect X-rays, ultrasounds, radiowaves and microwaves and fluorophores.

### Claim 42 (depends on 30)

The biodegradable biocompatible polyketal of claim 30 wherein said diagnostic label is selected from the group consisting of: radiopharmaceutical or radioactive isotopes for gamma scintigraphy and PET, contrast agent for Magnetic Resonance Imaging (MRI), contrast agent for computed tomography, contrast agent for X-ray imaging method, agent for ultrasound diagnostic method, agent for neutron activation, moiety which can reflect, scatter or affect X-rays, ultrasounds, radiowaves and microwaves and fluorophores.

### Claim 43

A method for forming a biodegradable biocompatible polyketal, comprising steps of:
a) reacting an effective amount of an oxidizing agent with a polysaccharide to form a biodegradable biocompatible polyketal aldehyde;
b) optionally treating the biodegradable biocompatible polyketal aldehyde with a suitable reagent under suitable conditions to form said biodegradable biocompatible polyketal polymer; and
c) optionally repeating step b) until the desired functionalization of said biodegradable biocompatible polyketal is achieved;
thereby forming a biodegradable biocompatible polyketal comprising repeat structural units, wherein substantially all the structural units comprise:
i) at least one ketal group wherein at least one ketal oxygen atom is within the polymer main chain; and
ii) at least one hydrophilic group or pharmaceutically useful group.

### Claim 44 (depends on 43)

The method of claim 43 wherein in the biodegradable biocompatible polyketal at least a subset of the structural units have the structure:
wherein each occurrence of R1 and R2 is a biocompatible group and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is a biocompatible group and is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3, R4, R5 and R6 is a hydrophilic group or a pharmaceutically useful group.

### Claim 45 (depends on 43)

The method of claim 43 wherein in the biodegradable biocompatible polyketal at least a subset of the structural units have the structure:
wherein each occurrence of R1 is a biocompatible group;
each occurrence of R2 is a biocompatible group and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C1;
n is an integer;
each occurrence of R1, R3 and R4 is a biocompatible group and is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3 and R4 is a hydrophilic group or a pharmaceutically useful group.

### Claim 46

A method for forming a biodegradable biocompatible polyketal, comprising steps of:
a) reacting a suitable initiator with a compound having the chemical structure:
thereby forming a polymer intermediate comprising the chemical structure:
wherein each occurrence of P1 and P2 is independently an organic moiety or a protected organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Px is an organic moiety and includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of P3, P4, P5 and P6 is independently hydrogen, an organic moiety or a protected organic moiety; and
for each occurrence of the bracketed structure n, at least one of P1, P2, P3, P4, P5 and P6 is a protected hydrophilic group or a pharmaceutically useful group;
b) optionally reacting said polymer intermediate with a suitable reagent under suitable conditions to form second polymer intermediate; and
c) optionally repeating step b) until the desired functionalization of said polymer intermediate is achieved;
thereby forming a polyketal comprising the structure:
wherein each occurrence of R1 and R2 is independently a biocompatible group and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is a biocompatible group and is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3, R4, R5 and R6 is a hydrophilic group or a pharmaceutically useful group.

### Claim 47 (depends on 46)

The method of claim 46 wherein in the polymer intermediate formed in step (a) each occurrence of said protected hydrophilic group is independently a carboxylic ester, an alkoxy group, a thioester, a thioether, a vinyl group or a haloalkyl group.

### Claim 48

A method for forming a crosslinked biodegradable biocompatible polyketal, comprising steps of:
a) reacting an effective amount of an oxidizing agent with a polysaccharide to form an aldehyde intermediate;
b) optionally treating the biodegradable biocompatible polyketal aldehyde formed in step (a) with a suitable reagent under suitable conditions to form a polyketal polymer intermediate;
c) optionally repeating step b) until the desired functionalization of said polyketal polymer intermediate is achieved; and
d) reacting said polyketal polymer intermediate with a crosslinking agent.

### Claim 49 (depends on 48)

The method of claim 48 wherein the crosslinking agent has the chemical structure:
X1—(R)—X2;
wherein R is a spacer group and wherein X1 and X2 are reactive groups.

### Claim 50 (depends on 49)

The method of claim 49 wherein the reactive groups X1 and X2 are independently selected from the group consisting of epoxides, halides, tosylates, carboxylates, aziridines, cyclopropanes, esters, N-oxysuccinimide esters, disulfides and anhydrides.

### Claim 51

A method for forming a crosslinked biodegradable biocompatible polyketal, comprising steps of:
a) reacting an effective amount of an oxidizing agent with a polysaccharide to form an aldehyde intermediate; and
b) reacting said aldehyde intermediate with a crosslinking agent.

### Claim 52 (depends on 51)

The method of claim 51 wherein said crosslinking agent has the chemical structure:
X1—(R)—X2;
wherein R is a spacer group and wherein X1 and X2 are reactive groups.

### Claim 53 (depends on 52)

The method of claim 52 wherein said reactive groups X1 and X2 are independently selected from the group consisting of: amines, polyols, thiols, alcohols, ketones, aldehydes, diazocompounds, boron derivatives, ylides, isonitriles, hydrazines and their derivatives and hydroxylamines and their derivatives.

### Claim 54

A method for forming a crosslinked biodegradable biocompatible polyketal, said method comprising steps of:
a) reacting a suitable initiator with a compound having the chemical structure:
thereby forming a polymer intermediate comprising the chemical structure:
wherein each occurrence of P1 and P2 is independently an organic moiety or a protected organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Px is an organic moiety which includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of P3, P4, P5 and P6 is independently hydrogen, an organic moiety or a protected organic moiety; and
for each occurrence of the bracketed structure n, at least one of P1, P2, P3, P4, P5 and P6 is a protected hydrophilic group or a pharmaceutically useful group;
b) optionally reacting said polymer intermediate with a suitable reagent under suitable conditions to form second polymer intermediate;
c) optionally repeating step b) until the desired functionalization of said polymer intermediate is achieved; and
d) reacting the biodegradable biocompatible polyketal formed in step c) with a crosslinking agent.

### Claim 55 (depends on 54)

The method of claim 54 wherein in the polymer intermediate formed in step (a) each occurrence of said protected hydrophilic group is independently a carboxylic ester, an alkoxy group, a thioester, a thioether, a vinyl group or a haloalkyl group.

### Claim 56 (depends on 54)

The method of claim 54 wherein said crosslinking agent has the chemical structure:
X1—(R)—X2;
wherein R is a spacer group and wherein X1 and X2 are reactive groups.

### Claim 57 (depends on 56)

The method of claim 56 wherein said reactive groups X1 and X2 are independently selected from the group consisting of: epoxides, halides, tosylates, carboxylates, aziridines, cyclopropanes, esters, N-oxysuccinimide esters, disulfides, anhydrides, amines, polyols, thiols, alcohols, ketones, aldehydes, diazocompounds, boron derivatives, ylides, isonitriles, hydrazines and their derivatives, and hydroxylamines and their derivatives.

### Claim at position 58

58-77. (canceled)

### Claim 78

A composition comprising the macromolecular product of the lateral cleavage of a polysaccharide; whereby at least one carbon-carbon bond is cleaved in substantially all the carbohydrate moieties of said polysaccharide.

### Claim 79 (depends on 78)

The composition of claim 78 wherein said lateral cleavage is effected using an oxidizing agent.

### Claim 80 (depends on 79)

The composition of claim 79 wherein said oxidizing agent is a glycol-specific agent.

### Claim 81 (depends on 80)

The composition of claim 80 wherein said glycol-specific agent is sodium periodate.

### Claim 82 (depends on 43, 44, 45, 48, 51)

A composition comprising the macromolecular product of the lateral cleavage of a polysaccharide; whereby at least one carbon-carbon bond is cleaved in substantially all the carbohydrate moieties of said polysaccharide;
wherein said macromolecular product is obtained by the method of claim 43, 44, 45, 48 or 51.

### Claim 83 (depends on 1, 2, 3)

A composition comprising a biodegradable biocompatible polyketal of claim 1, 2 or 3 associated with an effective amount of a therapeutic agent; wherein the therapeutic agent is incorporated into an released from said biodegradable biocompatible polyketal matrix by degradation of the polymer matrix or diffusion of the agent out of the matrix over a period of time.

### Claim at position 65

84-88. (canceled)

### Claim 89 (depends on 1, 2, 3)

An interface component comprising a biodegradable biocompatible polyketal of claim 1, 2 or 3.

### Claim 90 (depends on 89)

A composition comprising the interface component of claim 89 and a macromolecule, micelle, liposome or surface attached to the interface component.

### Claim at position 68

91-93. (canceled)

### Claim 94 (depends on 1, 2, 3)

A biomedical preparation comprising a biodegradable biocompatible polyketal, said biodegradable biocompatible polyketal including a compound of claim 1, 2 or 3.

### Claim 95 (depends on 94)

The biomedical preparation of claim 94 wherein the biomedical preparation is a fiber, gel or solution.

### Claim at position 71

96-97. (canceled)

### Claim 98 (depends on 1, 2, 3)

A method of administering to a patient in need of treatment, comprising administering to the subject an effective amount of a suitable therapeutic agent; wherein said therapeutic agent is associated with and released from a biodegradable biocompatible polyketal matrix of claims 1, 2 or 3 by degradation of the polymer matrix or diffusion of the agent out of the matrix over a period of time.

### Claim at position 73

99-104. (canceled)

### Claim 105

A chiral polymer, wherein said polymer comprises repeat structural units, wherein substantially all the structural units comprise:
a) at least one ketal group wherein at least one ketal oxygen atom is within the polymer main chain; and
b) at least one chiral group.

### Claim 106 (depends on 105)

The chiral polymer of claim 105 wherein at least a subset of the structural units have the structure:
wherein each occurrence of R1 and R2 is independently an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3, R4, R5 and R6 is chiral.

### Claim 107 (depends on 105)

The chiral polymer of claim 105 wherein at least a subset of the structural units have the structure:
wherein each occurrence of R2 is an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C1;
n is an integer;
each occurrence of R1, R3 and R4 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3 and R4 is chiral.

### Claim at position 77

108-110. (canceled)

### Claim 111 (depends on 106)

The chiral polymer of claim 106 wherein at least a subset of the repeat structural units have the structure:
wherein n is an integer.

### Claim 112 (depends on 107)

The chiral polymer of claim 107 wherein at least a subset of the repeat structural units have the structure:
wherein n is an integer.

### Claim 113 (depends on 105, 106, 107)

A crosslinked chiral polyketal, comprising a compound of claim 105, 106 or 107.

### Claim at position 81

114-118. (canceled)

### Claim 119 (depends on 105, 106, 107)

A composition comprising a chiral polymer of claim 105, 106 or 107 covalently bonded to an inorganic support material either directly or via a spacer grouping.

### Claim at position 83

120-121. (canceled)

### Claim 122

A method for preparing a chiral polymer, said method comprising steps of:
a) reacting an effective amount of an oxidizing agent with a polysaccharide to form a polyketal aldehyde;
b) optionally treating the polyketal aldehyde with a suitable reagent under suitable conditions to form a polyketal; and
c) optionally repeating step b) until the desired functionalization of said polyketal is achieved;
thereby forming a chiral polymer, wherein said polymer comprises repeat structural units, wherein substantially all the structural units comprise:
i) at least one ketal group wherein at least one ketal oxygen atom is within the polymer main chain; and
ii) at least one chiral group.

### Claim 123

A method for preparing a chiral polymer, said method comprising steps of:
a) reacting an effective amount of an oxidizing agent with a polysaccharide to form a polyketal aldehyde;
b) optionally treating the polyketal aldehyde with a suitable reagent to form a polyketal intermediate;
c) optionally repeating step b) until the desired functionalization of said polyketal intermediate is achieved; and
d) reacting said polyketal intermediate with a suitable chiral reagent;
thereby forming a chiral polymer, wherein said polymer comprises repeat structural units, wherein substantially all the structural units comprise:
i) at least one ketal group wherein at least one ketal oxygen atom is within the polymer main chain; and
ii) at least one chiral group.

### Claim 124 (depends on 122)

The method of claim 122 wherein in the chiral polyketal at least a subset of the repeat structural units have the structure:
wherein each occurrence of R1 and R2 is independently an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R1 and R6 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3, R4, R5 and R6 is chiral.

### Claim 125 (depends on 123)

The method of claim 123 wherein in the chiral polyketal at least a subset of the repeat structural units have the structure:
wherein each occurrence of R1 and R2 is independently an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3, R4, R5 and R6 is chiral.

### Claim 126 (depends on 122)

The method of claim 122 wherein in the chiral polyketal at least a subset of the repeat structural units have the structure:
wherein each occurrence of R2 is an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C1;
n is an integer;
each occurrence of R1, R3 and R4 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3 and R4 is chiral.

### Claim 127 (depends on 123)

The method of claim 123 wherein in the chiral polyketal at least a subset of the repeat structural units have the structure:
wherein each occurrence of R2 is an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C1;
n is an integer;
each occurrence of R1, R3 and R4 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3 and R4 is chiral.

### Claim 128

A method for forming a chiral polymer, said method comprising steps of:
a) reacting a suitable initiator with a compound having the chemical structure:
thereby forming a polymer intermediate comprising the chemical structure:
wherein each occurrence of P1 and P2 is independently an organic moiety or a protected organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Px is independently an organic moiety and includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of P3, P4, P5 and P6 is independently hydrogen, an organic moiety or a protected organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Px, P1, P2, P3, P4, P5 and P6 is chiral;
thereby forming a first polyketal intermediate;
b) optionally reacting said first polymer intermediate with a suitable reagent to form a second polyketal intermediate; and
c) optionally repeating step b) until the desired functionalization of said polyketal intermediate is achieved;
thereby forming a polyketal comprising the structure having the structure:
wherein each occurrence of R1 and R2 is independently an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of C1, C2, Rx, R1, R2, R3 and R4 is chiral.

### Claim 129

A method for forming a chiral polymer, said method comprising steps of:
a) reacting a suitable initiator with a compound having the chemical structure:
thereby forming a polymer intermediate comprising the chemical structure:
wherein each occurrence of P1 and P2 is an organic moiety or a protected organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Px is an organic moiety which includes a carbon atom covalently attached to C2;
n is an integer; and
each occurrence of P3, P4, P5 and P6 is independently hydrogen, an organic moiety or a protected organic moiety;
b) reacting said polymer intermediate with a suitable reagent to form a second polymer intermediate; and
c) optionally repeating step b) until the desired functionalization of said second polymer intermediate is achieved; whereby at least one reagent used in steps (b) through (c) is chiral;
thereby forming a chiral polyketal comprising the structure:
wherein each occurrence of R1 and R2 is independently an organic moiety and includes a carbon atom covalently attached to C1;
each occurrence of Rx includes a carbon atom covalently attached to C2;
n is an integer;
each occurrence of R3, R4, R5 and R6 is independently hydrogen or an organic moiety; and
for each occurrence of the bracketed structure n, at least one of R1, R2, R3, R4, R5 and R6 is chiral.

### Claim at position 92

130-145. (canceled)

### Claim 146

A composition comprising a chiral polyketal; wherein said chiral polyketal is the macromolecular product of the lateral cleavage of a polysaccharide; whereby at least one carbon-carbon bond is cleaved in substantially all the carbohydrate moieties of said polysaccharide.

### Claim 147 (depends on 146)

The composition of claim 146 wherein said cleavage is effected using an oxidizing agent.

### Claim 148 (depends on 147)

The composition of claim 147 wherein said oxidizing agent is a glycol-specific agent.

### Claim 149 (depends on 148)

The composition of claim 148 wherein said glycol-specific agent is sodium periodate.

### Claim 150 (depends on 147)

The composition of claim 147 wherein said oxidizing agent is non-specific ans is used in combination with a glycol-specific catalyst.

### Claim 151 (depends on 122, 123, 124, 125, 126, 127, 128, 129)

A composition comprising a chiral polyketal; wherein said chiral polyketal is the macromolecular product of the lateral cleavage of a polysaccharide; whereby at least one carbon-carbon bond is cleaved in substantially all the carbohydrate moieties of said polysaccharide;
wherein said macromolecular product is obtained by the method of claim 122, 123, 124, 125, 126, 127, 128 or 129.

### Claim 152 (depends on 105, 106, 107)

A process for the separation of optical isomers comprising using a chiral polymer of claim 105, 106 or 107 to effect the separation.

### Claim 153 (depends on 119)

A process for the separation of optical isomers comprising using a chiral polymer bonded to a support according to claim 119 to effect the separation.

### Claim 154 (depends on 105, 106, 107)

A chiral compound; said compound being the depolymerization product of the chiral polyketal of claim 105, 106 or 107.

### Claim 155 (depends on 122, 123, 124, 125, 126, 127)

A chiral compound, said compound being the depolymerization product of the chiral polyketal; wherein said chiral polyketal is prepared by the method of claim 122, 123, 124, 125, 126 or 127.

### Claim 156 (depends on 105, 106, 107)

A method for generating chiral compounds; said method comprising the step, of depolymerizing under suitable conditions the chiral polyketal of claim 105, 106 or 107.

### Claim 157 (depends on 122, 123, 124, 125, 126, 127)

A method for generating chiral compounds; said method comprising the step of depolymerizing under suitable conditions a chiral polyketal, wherein said chiral polyketal is prepared by the method of claim 122, 123, 124, 125, 126 or 127.
